Berger montague pc investigating claims on behalf of spectrum pharmaceuticals, inc. (nasdaq: sppi) investors

Philadelphia , aug. 6, 2025 /prnewswire/ -- national plaintiffs' law firm berger montague pc  is investigating securities fraud claims against spectrum pharmaceuticals, inc. (nasdaq: sppi) ("spectrum" or the "company") on behalf of investors who purchased or otherwise acquired common shares of spectrum between  march 17, 2022 through september 22, 2022 (the "class period"). investor deadline:  investors who purchased or acquired spectrum securities during the class period may, no later than september 24, 2025 , seek to be appointed as a lead plaintiff representative of the class.
ASRT Ratings Summary
ASRT Quant Ranking